Helen Tate

522 total citations
21 papers, 389 citations indexed

About

Helen Tate is a scholar working on Physiology, Cardiology and Cardiovascular Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Helen Tate has authored 21 papers receiving a total of 389 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Physiology, 3 papers in Cardiology and Cardiovascular Medicine and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Helen Tate's work include Asthma and respiratory diseases (4 papers), Statistical Methods in Clinical Trials (3 papers) and Cardiovascular Disease and Adiposity (2 papers). Helen Tate is often cited by papers focused on Asthma and respiratory diseases (4 papers), Statistical Methods in Clinical Trials (3 papers) and Cardiovascular Disease and Adiposity (2 papers). Helen Tate collaborates with scholars based in United Kingdom, United States and Canada. Helen Tate's co-authors include Neil Barnes, Mike Thomas, David Price, Katherine Wasson, A Bagust, David Cameron, Sorrel Wolowacz, Warren B. Gefter, Ana M. Valdes and Megan L. Wolfe and has published in prestigious journals such as Journal of Clinical Oncology, Kidney International and Journal of Allergy and Clinical Immunology.

In The Last Decade

Helen Tate

19 papers receiving 367 citations

Peers

Helen Tate
Anthony E. Voytovich United States
Isabelle N Colmers-Gray Canada
Cornelis Biesheuvel Australia
Asad Mian Pakistan
Osama Ishtiaq Pakistan
Kunal Kothari India
Wenli Wang China
Tanya Burton United States
Richard L. Mowery United States
Hélène Chevrou‐Séverac Switzerland
Anthony E. Voytovich United States
Helen Tate
Citations per year, relative to Helen Tate Helen Tate (= 1×) peers Anthony E. Voytovich

Countries citing papers authored by Helen Tate

Since Specialization
Citations

This map shows the geographic impact of Helen Tate's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helen Tate with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helen Tate more than expected).

Fields of papers citing papers by Helen Tate

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Helen Tate. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helen Tate. The network helps show where Helen Tate may publish in the future.

Co-authorship network of co-authors of Helen Tate

This figure shows the co-authorship network connecting the top 25 collaborators of Helen Tate. A scholar is included among the top collaborators of Helen Tate based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Helen Tate. Helen Tate is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Jones, Byron, et al.. (2011). Statistical approaches for conducting network meta‐analysis in drug development. Pharmaceutical Statistics. 10(6). 523–531. 43 indexed citations
3.
4.
Wolowacz, Sorrel, David Cameron, Helen Tate, & A Bagust. (2008). Docetaxel in Combination With Doxorubicin and Cyclophosphamide As Adjuvant Treatment for Early Node-Positive Breast Cancer: A Cost-Effectiveness and Cost-Utility Analysis. Journal of Clinical Oncology. 26(6). 925–933. 30 indexed citations
5.
Barnes, Neil, Michel Laviolette, David J. Allen, et al.. (2007). Effects of montelukast compared to double dose budesonide on airway inflammation and asthma control. Respiratory Medicine. 101(8). 1652–1658. 16 indexed citations
6.
Taylor, Stephanie, Russell Viner, Robert Booy, et al.. (2005). Ethnicity, Socio-economic Status, Overweight and Underweight in East London Adolescents. Ethnicity and Health. 10(2). 113–128. 54 indexed citations
7.
Barnes, Neil, Mike Thomas, David Price, & Helen Tate. (2005). The national montelukast survey. Journal of Allergy and Clinical Immunology. 115(1). 47–54. 40 indexed citations
8.
Pearson, M, et al.. (2004). Evaluating the effectiveness of asthma treatment in real‐life practice. Journal of Evaluation in Clinical Practice. 10(2). 297–305. 10 indexed citations
9.
Tate, Helen, et al.. (2004). Voices About Choices: The Role of Female Networks in Affirming Life Choices in the Academy. Women s Studies in Communication. 27(1). 88–110. 2 indexed citations
10.
Griffiths, Chris, Gill Foster, Gene Feder, Helen Tate, & Sandra Eldridge. (2002). Can asthma liaison nurses reduce unscheduled care in a deprived multi-ethnic population? ELECTRA: the east London controlled trial for high-risk asthma. Primary Care Respiratory Journal. 11(2). 59–59. 2 indexed citations
11.
12.
Wasson, Katherine, et al.. (2001). Food refusal and dysphagia in older people with dementia: ethical and practical issues. International Journal of Palliative Nursing. 7(10). 465–471. 27 indexed citations
13.
White, Kenneth E., et al.. (2000). Measurement of glomerular volume in needle biopsy specimens. Nephrology Dialysis Transplantation. 15(2). 239–243. 15 indexed citations
14.
White, Kathryn, et al.. (1997). Efficient morphometric analysis of glomerular mesangium in insulin-dependent diabetic patients with early nephropathy. Kidney International. 51(5). 1624–1628. 9 indexed citations
15.
Tate, Helen, et al.. (1996). A meta-analysis of clinical studies of imipenem-cilastatin for empirically treating febrile neutropenic patients. Journal of Antimicrobial Chemotherapy. 37(5). 975–986. 22 indexed citations
16.
Tate, Helen. (1987). 24. The Timing of Tests in Tumor Monitoring. Tumor Biology. 8(2-3). 179–180.
17.
Tate, Helen. (1983). A Bayesian Approach to the Analysis of Serial Tumour-Marker Data. Journal of the Royal Statistical Society Series D (The Statistician). 32(1/2). 116–116. 1 indexed citations
18.
Tate, Helen. (1983). Assessing tumour markers. Statistics in Medicine. 2(2). 217–222. 1 indexed citations
19.
Tate, Helen. (1982). Plasma CEA in the post-surgical monitoring of colorectal carcinoma. British Journal of Cancer. 46(3). 323–330. 35 indexed citations
20.
Tate, Helen. (1981). Assessing tumour markers. British Journal of Cancer. 44(5). 643–651. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anthony E. Voytovich Breakdown of academic impact, for papers by Isabelle N Colmers-Gray Breakdown of academic impact, for papers by Cornelis Biesheuvel Breakdown of academic impact, for papers by Asad Mian Breakdown of academic impact, for papers by Osama Ishtiaq Breakdown of academic impact, for papers by Kunal Kothari Breakdown of academic impact, for papers by Wenli Wang Breakdown of academic impact, for papers by Tanya Burton Breakdown of academic impact, for papers by Richard L. Mowery Breakdown of academic impact, for papers by Hélène Chevrou‐Séverac
Rankless by CCL
2026